Sevilay Altıntaş
- Oncology top 10%
- Cancer Research top 10%
- Hematology top 5%
- Genetics top 10%
- Molecular Biology
- Co-authors
- Wiebren TjalmaManon HuizingPeter A. van DamLaurent BastitA. VandebroekTamás PintérTamás SütöZwi Berneman
- Topics
- Breast Cancer Treatment Studies (14 papers)Cancer Treatment and Pharmacology (9 papers)HER2/EGFR in Cancer Research (7 papers)
- Cited by
- HematologyGeneticsCancer Research
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Sevilay Altıntaş
39 papers receiving 733 citations
Peers
Comparison fields: 5 of 95
- Oncology 291
- Cancer Research 188
- Hematology 164
- Genetics 137
- Molecular Biology 122
Countries citing papers authored by Sevilay Altıntaş
This map shows the geographic impact of Sevilay Altıntaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevilay Altıntaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevilay Altıntaş more than expected).
Fields of papers citing papers by Sevilay Altıntaş
This network shows the impact of papers produced by Sevilay Altıntaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevilay Altıntaş. The network helps show where Sevilay Altıntaş may publish in the future.
Co-authorship network of co-authors of Sevilay Altıntaş
This figure shows the co-authorship network connecting the top 25 collaborators of Sevilay Altıntaş. A scholar is included among the top collaborators of Sevilay Altıntaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevilay Altıntaş. Sevilay Altıntaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | 11 | |
| 8 | 45 | |
| 9 | 41 | |
| 10 | 81 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 9 | |
| 14 | 14 | |
| 15 | Ductal carcinoma in situ: a disease entity that merits more recognition. | 2 |
| 16 | 3 | |
| 17 | 15 | |
| 18 | 44 | |
| 19 | 8 | |
| 20 | 17 |
About Sevilay Altıntaş
Sevilay Altıntaş is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 42 papers that have together received 749 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (14 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (7 papers). The work is most often cited by research in Hematology (164 citations), Genetics (137 citations) and Cancer Research (188 citations). Sevilay Altıntaş has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Wiebren Tjalma, Manon Huizing, Peter A. van Dam, Laurent Bastit, A. Vandebroek, Tamás Pintér, Tamás Sütö, Zwi Berneman, Jan B. Vermorken and Marc Peeters. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.